Stock Analysis, Dividends, Split History

ENUM / Enumeral Biomedical Holdings, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price0.10
Volume2,500.00
Market Cap ($M)12.97
Enterprise Value ($M)12.76
Book Value ($M)-1.16
Book Value / Share-0.01
Price / Book-11.20
NCAV ($M)-1.16
NCAV / Share-0.01
Price / NCAV-11.16
Share Statistics
Preferred Stock Shares Outstanding 0
Common Shares Outstanding 128,409,788
Common Stock Shares Outstanding 128,343,122
Scoring Models
Piotroski F-Score1.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-3.03
Return on Assets (ROA)-1.87
Return on Equity (ROE)-4.79
Balance Sheet (mrq) ($M)
Assets0.53
Liabilities1.69
Quick Ration/a
Current Ratio0.31
Income Statement (mra) ($M)
License And Services Revenue1,999,666.00
Revenue From Grants453,202.00
Sales Revenue Services Net2,452,868.00
Operating Income-6.97
Net Income-11.86
Earnings Per Share Diluted-0.21
Earnings Per Share Basic-0.21
Cash Flow Statement (mra) ($M)
Cash From Operations-5.67
Cash from Financing-5.67
Identifiers and Descriptors
CUSIP294017108
Central Index Key (CIK)1561551

Split History

Stock splits are used by Enumeral Biomedical Holdings, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon
CUSIP: 294017108